The Europe Intraoperative Neuromonitoring Market would witness market growth of 5.6% CAGR during the forecast period (2023-2030).
The expanding range of applications for IONM across various surgical specialties has broadened its appeal. Initially prevalent in neurosurgery, IONM is utilized in orthopedic, spinal, otolaryngology, and vascular surgeries. The versatility of IONM in safeguarding different neural structures has led to its integration into a diverse array of surgical disciplines. The economic considerations associated with surgical procedures also influence the adoption of IONM. While the initial investment in IONM technology may be significant, the potential cost savings associated with preventing complications and reducing the need for postoperative interventions make it an economically viable choice for many healthcare institutions.
As patients become more informed about advancements in healthcare, they may actively seek out surgeons and healthcare facilities that offer IONM as part of their surgical protocols. The growing awareness among patients about the potential benefits of IONM creates a demand-driven incentive for its adoption by healthcare providers. The detection and preservation of important neural structures during surgery is one of the main applications of IONM. In procedures involving the brain, spinal cord, peripheral nerves, and cranial nerves, IONM helps surgeons precisely locate and navigate these structures, reducing the risk of unintentional damage.
As per Destatis, 2020, since younger birth cohorts also show decreasing numbers of people, over 65-year-olds make up an ever-larger proportion of the total population over time. It rose from 15% in 1991 to 22 % in 2019. The group of the very old, above 85, is particularly fast growing. Their number increased from 1.2 million in 1991 to 2.4 million in 2019. Similarly, according to a report on the French aging policy published by the UN, as in other European countries, France faces a continuous and significant increase in elderly people. The nation had 15 million people aged more than 60 in France in 2012, expected to reach 24 million in 2060. Hence, all these factors will uplift the regional market’s expansion in the coming years.
The Germany market dominated the Europe Intraoperative Neuromonitoring Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $469.8 million by 2030. The UK market is exhibiting a CAGR of 4.7% during (2023 - 2030). Additionally, The France market would experience a CAGR of 6.4% during (2023 - 2030).
Based on Source Type, the market is segmented into Insourced Monitoring, and Outsourced Monitoring. Based on End User, the market is segmented into Hospitals, and Ambulatory Surgical Centers (ASCs). Based on Products & Services, the market is segmented into Services, Systems, and Accessories. Based on Application, the market is segmented into Spinal Surgery, Neurosurgery, Orthopedic Surgery, ENT Surgery, Vascular Surgery, and Others. Based on Modality, the market is segmented into Electromyography (EMG), Electroencephalography (EEG), Motor Evoked Potentials (MEPs), Somatosensory Evoked Potentials (SSEPs), Visual Evoked Potentials (VEPs), and Brainstem Auditory Evoked Potentials (BAEPs). Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The expanding range of applications for IONM across various surgical specialties has broadened its appeal. Initially prevalent in neurosurgery, IONM is utilized in orthopedic, spinal, otolaryngology, and vascular surgeries. The versatility of IONM in safeguarding different neural structures has led to its integration into a diverse array of surgical disciplines. The economic considerations associated with surgical procedures also influence the adoption of IONM. While the initial investment in IONM technology may be significant, the potential cost savings associated with preventing complications and reducing the need for postoperative interventions make it an economically viable choice for many healthcare institutions.
As patients become more informed about advancements in healthcare, they may actively seek out surgeons and healthcare facilities that offer IONM as part of their surgical protocols. The growing awareness among patients about the potential benefits of IONM creates a demand-driven incentive for its adoption by healthcare providers. The detection and preservation of important neural structures during surgery is one of the main applications of IONM. In procedures involving the brain, spinal cord, peripheral nerves, and cranial nerves, IONM helps surgeons precisely locate and navigate these structures, reducing the risk of unintentional damage.
As per Destatis, 2020, since younger birth cohorts also show decreasing numbers of people, over 65-year-olds make up an ever-larger proportion of the total population over time. It rose from 15% in 1991 to 22 % in 2019. The group of the very old, above 85, is particularly fast growing. Their number increased from 1.2 million in 1991 to 2.4 million in 2019. Similarly, according to a report on the French aging policy published by the UN, as in other European countries, France faces a continuous and significant increase in elderly people. The nation had 15 million people aged more than 60 in France in 2012, expected to reach 24 million in 2060. Hence, all these factors will uplift the regional market’s expansion in the coming years.
The Germany market dominated the Europe Intraoperative Neuromonitoring Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $469.8 million by 2030. The UK market is exhibiting a CAGR of 4.7% during (2023 - 2030). Additionally, The France market would experience a CAGR of 6.4% during (2023 - 2030).
Based on Source Type, the market is segmented into Insourced Monitoring, and Outsourced Monitoring. Based on End User, the market is segmented into Hospitals, and Ambulatory Surgical Centers (ASCs). Based on Products & Services, the market is segmented into Services, Systems, and Accessories. Based on Application, the market is segmented into Spinal Surgery, Neurosurgery, Orthopedic Surgery, ENT Surgery, Vascular Surgery, and Others. Based on Modality, the market is segmented into Electromyography (EMG), Electroencephalography (EEG), Motor Evoked Potentials (MEPs), Somatosensory Evoked Potentials (SSEPs), Visual Evoked Potentials (VEPs), and Brainstem Auditory Evoked Potentials (BAEPs). Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Nihon Kohden Corporation
- inomed Medizintechnik GmbH
- Medtronic PLC
- SpecialtyCare, Inc. (Morgan Stanley)
- NeuroStyle Pte. Ltd.
- Computational Diagnostics, Inc.
- Accurate Neuromonitoring, LLC (Housatonic Partners)
- Intranerve Neuroscience Holdings, Llc
- Natus Medical Incorporated (Archimed SAS)
- Globus Medical, Inc.
Market Report Segmentation
By Source Type- Insourced Monitoring
- Outsourced Monitoring
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Services
- Systems
- Accessories
- Spinal Surgery
- Neurosurgery
- Orthopedic Surgery
- ENT Surgery
- Vascular Surgery
- Others
- Electromyography (EMG)
- Electroencephalography (EEG)
- Motor Evoked Potentials (MEPs)
- Somatosensory Evoked Potentials (SSEPs)
- Visual Evoked Potentials (VEPs)
- Brainstem Auditory Evoked Potentials (BAEPs)
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Europe Intraoperative Neuromonitoring Market by Source Type
Chapter 5. Europe Intraoperative Neuromonitoring Market by End User
Chapter 6. Europe Intraoperative Neuromonitoring Market by Products & Services
Chapter 7. Europe Intraoperative Neuromonitoring Market by Application
Chapter 8. Europe Intraoperative Neuromonitoring Market by Modality
Chapter 9. Europe Intraoperative Neuromonitoring Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- Nihon Kohden Corporation
- inomed Medizintechnik GmbH
- Medtronic PLC
- SpecialtyCare, Inc. (Morgan Stanley)
- NeuroStyle Pte. Ltd.
- Computational Diagnostics, Inc.
- Accurate Neuromonitoring, LLC (Housatonic Partners)
- Intranerve Neuroscience Holdings, Llc
- Natus Medical Incorporated (Archimed SAS)
- Globus Medical, Inc.
Methodology
LOADING...
